Abstract
Background
Smoking is a known risk factor for perioperative complications after lung resection; however, little data exists looking at the impact of smoking status (current versus former) on long-term oncologic outcomes after lung cancer surgery. We sought to compare overall survival (OS), progression-free survival (PFS), and cancer-specific mortality (CSM) in current and former smokers using data from the National Lung Screening Trial (NLST). Additionally, we performed subset analysis in current smokers in order to evaluate the effect of modern surgical techniques on long-term outcomes.
Methods
Patients with clinical stage IA or IB NSCLC who underwent upfront resection within 180 days of diagnosis were identified in the NLST database. Cox proportional hazard regression models were used to assess differences in patient and treatment characteristics with respect to OS and PFS, with a cause-specific hazard model used for CSM.
Results
A total of 593 patients were included in the study (269 former smokers, 324 current smokers). Lobar resection (LR) was performed more often than sublobar resection (SLR) (481 vs. 112), and thoracotomy was performed more often than thoracoscopy (482 vs. 86). Comparison of current versus former smokers showed no difference in OS or PFS after resection. Higher CSM was seen in current smokers (p = 0.049). Subset analysis of current smokers revealed no difference in OS or PFS between sub-lobar and lobar resection or thoracotomy and thoracoscopy. Although higher CSM was associated with thoracoscopy versus thoracotomy in this group, this finding was limited by a relatively small thoracoscopy sample size of 44 patients (p = 0.026).
Conclusion
Our analysis of the NLST database shows no significant difference in OS and PFS when comparing current and former smokers undergoing resection for stage I NSCLC. Active smoking status was associated with higher CSM. Subset analysis of current smokers showed no difference in OS or PFS between sub-lobar and lobar resection or thoracotomy and thoracoscopy. Higher CSM was seen in current smokers who underwent thoracoscopy compared to thoracotomy; however, this finding was limited by a small sample size.
Similar content being viewed by others
Abbreviations
- BMI:
-
Body mass index
- CSM:
-
Cancer specific mortality
- HR:
-
Hazards ratio
- OS:
-
Overall survival
- PFS:
-
Progression free survival
- LR:
-
Lobar resection
- NLST:
-
National lung screening trial
- NSCLC:
-
Non-small cell lung cancer
- SLR:
-
Sublobar resection
- VATS:
-
Video-assisted thoracoscopic surgery
References
Fukui M, Suzuki K, Matsunaga T, Oh S, Takamochi K (2019) Importance of smoking cessation on surgical outcome in primary lung cancer. Ann Thorac Surg 107:1005–1009
Lugg ST, Tikka T, Agostini PJ et al (2017) Smoking and timing of cessation on postoperative pulmonary complications after curative-intent lung cancer surgery. J Cardiothorac Surg 12:52
Mason DP, Subramanian S, Nowicki ER et al (2009) Impact of smoking cessation before resection of lung cancer: a Society of Thoracic Surgeons General Thoracic Surgery Database study. Ann Thorac Surg 88:362–371
Sawabata N, Miyoshi S, Matsumura A et al (2007) Prognosis of smokers following resection of pathological stage I non-small-cell lung carcinoma. Gen Thorac Cardiovasc Surg 55:420–424
Poullis M, McShane J, Shaw M et al (2013) Smoking status at diagnosis and histology type as determinants of long-term outcomes of lung cancer patients. Eur J Cardiothorac Surg 43:919–924
Koike T, Yamato Y, Yoshiya K et al (2003) Intentional limited pulmonary resection for peripheral T1 N0 M0 small-sized lung cancer. J Thorac Cardiovasc Surg 125:924–928
Keenan RJ, Landreneau RJ, Maley RH Jr et al (2004) Segmental resection spares pulmonary function in patients with stage I lung cancer. Ann Thorac Surg 78:228–233
Harada H, Okada M, Sakamoto T, Matsuoka H, Tsubota N (2005) Functional advantage after radical segmentectomy versus lobectomy for lung cancer. Ann Thorac Surg 80:2041–2045
Okada M, Nishio W, Sakamoto T et al (2005) Effect of tumor size on prognosis in patients with non-small cell lung cancer: the role of segmentectomy as a type of lesser resection. J Thorac Cardiovasc Surg 129:87–93
Yoshida J, Nagai K, Yokose T et al (2005) Limited resection trial for pulmonary ground-glass opacity nodules: fifty-case experience. J Thorac Cardiovasc Surg 129:991–996
Altorki NK, Yip R, Hanaoka T et al (2014) Sublobar resection is equivalent to lobectomy for clinical stage 1A lung cancer in solid nodules. J Thorac Cardiovasc Surg 147:754–764
Dziedzic R, Żurek W, Marjański T et al (2017) Stage I non-small-cell lung cancer: long-term results of lobectomy versus sublobar resection from the Polish National Lung Cancer Registry. Eur J Cardiothorac Surg 52:363–369
Kates M, Swanson S, Wisnivesky JP (2011) Survival following lobectomy and limited resection for the treatment of stage I non-small cell lung cancer<=1 cm in size: a review of SEER data. Chest 139:491–496
Wisnivesky JP, Henschke CI, Swanson S et al (2010) Limited resection for the treatment of patients with stage IA lung cancer. Ann Surg 251:550–554
Paul S, Altorki NK, Sheng S et al (2010) Thoracoscopic lobectomy is associated with lower morbidity than open lobectomy: a propensity-matched analysis from the STS database. J Thorac Cardiovasc Surg 139:366–378
Flores RM, Park BJ, Dycoco J et al (2009) Lobectomy by video-assisted thoracic surgery (VATS) versus thoracotomy for lung cancer. J Thorac Cardiovasc Surg 138:11–18
Falcoz PE, Puyraveau M, Thomas PA et al (2016) Video-assisted thoracoscopic surgery versus open lobectomy for primary non-small-cell lung cancer: a propensity-matched analysis of outcome from the European Society of Thoracic Surgeon database. Eur J Cardiothorac Surg 49:602–609
Al-Ameri M, Bergman P, Franco-Cereceda A, Sartipy U (2018) Video-assisted thoracoscopic versus open thoracotomy lobectomy: a Swedish nationwide cohort study. J Thorac Dis 10:3499–3506
Long H, Tan Q, Luo Q et al (2018) Thoracoscopic surgery versus thoracotomy for lung cancer: short-term outcomes of a randomized trial. Ann Thorac Surg 105:386–392
Lee PC, Nasar A, Port JL et al (2013) Long-term survival after lobectomy for non-small cell lung cancer by video-assisted thoracic surgery versus thoracotomy. Ann Thorac Surg 96:951–961
Paul S, Isaacs AJ, Treasure T et al (2014) Long term survival with thoracoscopic versus open lobectomy: propensity matched comparative analysis using SEER-Medicare database. BMJ. 349:g5575
Fujisawa T, Iizasa T, Saitoh Y et al (1999) Smoking before surgery predicts poor long-term survival in patients with stage I non-small-cell lung carcinomas. J Clin Oncol 17:2086–2091
Ripley RT, McMillan RR, Sima CS et al (2014) Second primary lung cancers: smokers versus nonsmokers after resection of stage I lung adenocarcinoma. Ann Thorac Surg 98:968–974
Higuchi M, Yaginuma H, Yonechi A et al (2014) Long-term outcomes after video-assisted thoracic surgery (VATS) lobectomy versus lobectomy via open thoracotomy for clinical stage IA non-small cell lung cancer. J Cardiothorac Surg 9:88
Yang HX, Woo KM, Sima CS et al (2017) Long-term survival based on the surgical approach to lobectomy for clinical stage i nonsmall cell lung cancer: comparison of robotic, video-assisted thoracic surgery, and thoracotomy lobectomy. Ann Surg 265:431–437
Kneuertz PJ, D’Souza DM, Richardson M, Abdel-Rasoul M, Moffatt-Bruce SD, Merritt RE (2020) Long-term oncologic outcomes after robotic lobectomy for early-stage non-small-cell lung cancer versus video-assisted thoracoscopic and open thoracotomy approach. Clin Lung Cancer 21(214–224):e2
Kamel MK, Lee B, Harrison S et al (2019) Do the surgical results in the National Lung Screening Trial reflect modern thoracic surgical practice? J Thorac Cardiovasc Surg. 157(2038–2046):e1
Funding
This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
There are no conflicts of interest reported by any author.
Ethical approval
This study was approved by our institutional review board, IRB protocol No. 17–67.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Appendix
Appendix
See Table 4.
Rights and permissions
About this article
Cite this article
Sesti, J., Decker, J., Bell, J. et al. Long-term Outcomes After Lung Cancer Resection in Smokers: Analysis of the National Lung Screening Trial. World J Surg 46, 265–271 (2022). https://doi.org/10.1007/s00268-021-06311-0
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00268-021-06311-0